Proper interpretation and analysis of censored events and studies that contain them

Abstract

Get full access to this article

View all access options for this article.

References

Rudick R , Cutter GR , Baier M , Weinstock-Guttman B , Mass MK , Fisher E. et al. Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients . Mult Scler 2005; 11: 626-634 .

Jacobs LD , Cookfair DL , Rudick RA , Herndon RM , Richert JR , Salazar AM et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis . Ann Neurol 1996; 39: 285-294 .

Filippini G , Munari L , Incorvaia B , Ebers GC , Polman C , D’Amico R et al. Interferons in relapsing remitting multiple sclerosis: a systematic review . Lancet 2003; 361: 545-552 .

Rudick R , Cookfair DL , Griffin J , Hauser S , Piantadosi S. Interferons in relapsing remitting multiple sclerosis (letter) . Lancet 2003; 361: 1824-1824 .

Filippini G , Munari L , Incorvaia B , Ebers GC , Polman C , D’Amico R et al. Interferons in relapsing remitting multiple sclerosis: authors’ reply (letter) . Lancet 2003; 361: 1824-1825 .